Myron S. Cohen

Research interests

Publications

• Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

  The Lancet · 2022 · 10.1016/s0140-6736(22)00538-4

• Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

  New England Journal of Medicine · 2021 · 10.1056/nejmoa2101016

• A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

  Science Translational Medicine · 2021 · 10.1126/scitranslmed.abl7430

• SARS-CoV-2 Variants in Patients with Immunosuppression

  New England Journal of Medicine · 2021 · 10.1056/nejmsb2104756

• Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

  New England Journal of Medicine · 2021 · 10.1056/nejmoa2109682

• Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2031738

• Antiretroviral Therapy for the Prevention of HIV-1 Transmission

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1600693

• Structure and immune recognition of trimeric pre-fusion HIV-1 Env

  Nature · 2014 · https://doi.org/10.1038/nature13808

• Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

  The Lancet Infectious Diseases · 2014 · 10.1016/s1473-3099(13)70692-3

• Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

  Nature · 2013 · https://doi.org/10.1038/nature12053

• Prevention of HIV-1 Infection with Early Antiretroviral Therapy

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1105243

• Acute HIV-1 Infection

  New England Journal of Medicine · 2011 · 10.1056/nejmra1011874

• Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection

  The Journal of Experimental Medicine · 2009 · 10.1084/jem.20090378

• Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants

  Journal of Virology · 2009 · 10.1128/jvi.02132-08

• The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection

  The Journal of Experimental Medicine · 2009 · 10.1084/jem.20090365

• Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

  Journal of Virology · 2008 · 10.1128/jvi.01708-08

• Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

  Proceedings of the National Academy of Sciences · 2008 · 10.1073/pnas.0802203105

• Detection of Acute Infections during HIV Testing in North Carolina

  New England Journal of Medicine · 2005 · 10.1056/nejmoa042291

• The role of sexually transmitted diseases in HIV transmission

  Nature Reviews Microbiology · 2004 · 10.1038/nrmicro794

• Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV

  The Journal of Infectious Diseases · 2004 · 10.1086/386333

• Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis

  The Lancet · 1998 · 10.1016/s0140-6736(98)90002-2

• Sexual Transmission of HIV

  New England Journal of Medicine · 1997 · 10.1056/nejm199704103361507

• Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

  The Lancet · 1997 · 10.1016/s0140-6736(97)02190-9

• Free radicals and phagocytic cells

  The FASEB Journal · 1995 · 10.1096/fasebj.9.2.7540156

• Mechanism of the luminol-dependent chemiluminescence of human neutrophils.

  The Journal of Immunology · 1982 · 10.4049/jimmunol.129.4.1589

Current projects

No projects listed.